Skip to main content
Clinical Trials/NL-OMON28856
NL-OMON28856
Completed
Not Applicable

Study to Reduce Antibiotic prescription in children Pneumonia: implementation of a validated decision rule to target antibiotic prescription in children with suspected community acquired pneumonia.

Erasmus MC - Sophia0 sites1,100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
children
Sponsor
Erasmus MC - Sophia
Enrollment
1100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Erasmus MC - Sophia

Eligibility Criteria

Inclusion Criteria

  • children aged 1 month – 5 years with fever (parent reported and/or measured during physical examination T \>38°C) with signs suspected of community acquired pneumonia (CAP)

Exclusion Criteria

  • \-febrile children with antibiotic treatment during the week prior to the ED visit
  • \-children with comorbidity, i.e. hemodynamic relevant cardiac disease, pulmonary, neurologic disease or (primary of secondary) immunodeficiency

Outcomes

Primary Outcomes

Not specified

Similar Trials